Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
Accumulated Depreciation
Aurinia Pharmaceuticals Inc
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Accumulated Depreciation
-$2.1m
|
CAGR 3-Years
-90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Accumulated Depreciation
-$7.3m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Accumulated Depreciation
-$2.5m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-90%
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurinia Pharmaceuticals Inc's Accumulated Depreciation?
Accumulated Depreciation
-2.1m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Accumulated Depreciation amounts to -2.1m USD.
What is Aurinia Pharmaceuticals Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
-90%
The average annual Accumulated Depreciation growth rates for Aurinia Pharmaceuticals Inc have been -90% over the past three years .